Redcare Pharmacy N.V., a leading European e-pharmacy, announced on November 10, 2025, that its Supervisory Board has designated Hendrik Krampe as a member of the Managing Board and Chief Financial Officer, effective December 1, 2025. Krampe succeeds Jasper Eenhorst, who stepped down to pursue new professional opportunities. The appointment is subject to consultation at the Annual General Meeting in April 2026.
Bjorn Soder, Chairman of the Supervisory Board, welcomed the planned appointment, stating, “With Hendrik, we are gaining an internationally experienced finance leader with a deep understanding of digital business models. His perspective from two of the world’s most successful online stores will help us build on our strong financial foundation and drive the next phase of profitable growth.”
Hendrik Krampe brings over 20 years of experience in financial management of fast-growing e-commerce businesses. Since 2014, he worked at Amazon, serving as Finance Director of the European marketplace business for the last eight years. Prior to Amazon, from 2004 to 2014, Krampe held various roles at eBay in Germany and the US, including Finance Director of eBay’s Retail Media business. His expertise in scaling digital businesses, particularly marketplaces and Retail Media, aligns with Redcare Pharmacy’s strategy to strengthen its core Rx and OTC business.
The appointment comes at a time of continued growth momentum following strong Q3 results. Krampe’s leadership is expected to support the company’s aim to capture economies of scale and improve profitability. “I am looking forward to joining Redcare Pharmacy at such an exciting stage of its development,” Krampe commented. “The company has built an excellent foundation for continued growth across all the markets it serves. I am impressed by the clear vision and deep expertise of the leadership team and the loyalty of its customers.”
Redcare Pharmacy, originally founded in 2001, is the leading e-pharmacy in Europe, active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands, and Switzerland. The company offers over 13.5 million active customers a wide range of more than 250,000 products, including prescription drugs in Germany, Switzerland, and the Netherlands. Listed on the Frankfurt Stock Exchange since 2016, Redcare Pharmacy has been a member of the MDAX selection index since June 2023.
For more information, view the original release on NewMediaWire.
